懒洋洋 发表于 2025-3-30 12:17:57

Emerging Biomarkers of Myocardial Ischemiao present to the emergency department with a complaint of chest pain therefore require substantial diagnostic effort to determine whether their symptoms are related to acute myocardial ischemia. Present diagnostic approaches are typically protocol driven and include serial electrocardiograms and bio

向外供接触 发表于 2025-3-30 14:10:33

http://reply.papertrans.cn/23/2220/221903/221903_52.png

epidermis 发表于 2025-3-30 19:48:51

Analytic Issues for Clinical Use of C-Reactive Proteintrated that slight increases in CRP concentration, within the normal range, can predict future vascular events, thus reflecting the inflammatory component of atherosclerosis. It was necessary to develop new high-sensitivity methods for this clinical application, and to establish cut points for risk

放逐 发表于 2025-3-30 20:50:09

http://reply.papertrans.cn/23/2220/221903/221903_54.png

overrule 发表于 2025-3-31 03:15:52

http://reply.papertrans.cn/23/2220/221903/221903_55.png

窝转脊椎动物 发表于 2025-3-31 08:11:55

Defining Myocardial Infarctionbased on the following biomarker criteria: Maximal concentration of troponin T or I exceeding the decision limit (99th percentile of the values for a reference control group) manifesting a dynamic pattern on at least one occasion during the first 24 h after the index clinical event; if the value is

阴谋小团体 发表于 2025-3-31 09:11:36

Cardiac Troponin After Revascularization Proceduresnical significance is less well established. However, clinical studies show that large elevations (more than five times ULN) are associated with worse prognosis. Cardiac troponin is elevated more frequently after PCI and CABG. A number of procedure-related factors contribute to the rises in troponin

Climate 发表于 2025-3-31 15:05:30

http://reply.papertrans.cn/23/2220/221903/221903_58.png

是剥皮 发表于 2025-3-31 17:33:06

http://reply.papertrans.cn/23/2220/221903/221903_59.png

技术 发表于 2025-3-31 21:57:15

Developing a Marker of Ischemiaong argument toward development of biochemical markers of myocardial ischemia. Nevertheless, there are many challenges to this effort. The physiology is complex, and it is complicated by the issues of chronicity, timing, and severity. The absence of a “gold standard” for diagnosis of unstable angina
页: 1 2 3 4 5 [6] 7
查看完整版本: Titlebook: Cardiovascular Biomarkers; Pathophysiology and David A. Morrow Book 2006 Humana Press 2006 cardiovascular.heart.heart disease.myocardial i